With prof­its lag­ging, Em­ma Walm­s­ley, Big Phar­ma's on­ly woman CEO, may once again be its low­est paid

Feb­ru­ary’s earn­ings weren’t kind to Glax­o­SmithK­line. Not on­ly had the UK drug­mak­er’s sales dropped amid the pan­dem­ic, but their years-long R&D piv­ot was go­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER